PETS: PetMed Express, Inc. - Summary | Jitta

PetMed Express, Inc.

NASDAQ:PETS

Price
$33.91
Loss Chance
43.1%
6.88JITTA SCORE
136.90%Over Jitta Line
Jitta Ranking
1,011 / 4,522
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (63)
Recent Business Performance (81)
Financial Strength (83)
Return to Shareholders (81)
Competitive Advantage (73)
Jitta Signs
Debt LevelLow Long Term Debt
Return on EquityConsistently High
Dividend PayoutIncreasing Every Year
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning decline from 2018-2021
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
6.88
136.90%
Internet and Direct Marketing Retail
7.01
16.94%
5.38
38.28%
4.25
19.57%
COMPANY DESCRIPTION
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.